SEC Form D · filed June 13, 2022
AnPac Bio-Medical Science Co., Ltd
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (22)
Jianhua Shao · Lishui, IsraelDirectorHe Yu · Lishui, IsraelExecFeng Guo · Lishui, IsraelDirectorWeidong Dai · Lishui, IsraelExecJinqiu Tang · Lishui, IsraelExecXuedong Du · Lishui, IsraelExecChris Chang Yu · Lishui, IsraelExec · DirectorSheng Liu · Lishui, IsraelDirectorAidong Chen · Lishui, IsraelExec · DirectorPu Xing · Lishui, IsraelDirectorRen Luo · Lishui, IsraelDirectorChris Chang Yu · Lishui, IsraelExec · DirectorSheng Liu · Lishui, IsraelDirectorJianhua Shao · Lishui, IsraelDirectorAidong Chen · Lishui, IsraelExec · DirectorPu Xing · Lishui, IsraelDirectorHe Yu · Lishui, IsraelExecFeng Guo · Lishui, IsraelDirectorWeidong Dai · Lishui, IsraelExecJinqiu Tang · Lishui, IsraelExecXuedong Du · Lishui, IsraelExecRen Luo · Lishui, IsraelDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗